SCHEMBL9366991

SCHEMBL9366991

Cc1ccc(C(Cc2ccccc2)N2CCCCC2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.79
CYP2C19 P33261 3/20 0.79
CYP3A4 P08684 2/20 0.79
CYP2D6 P10635 2/20 0.79
TSHR P16473 1/20 0.79
HRH3 Q9Y5N1 3/20 0.64
ALDH1A1 P00352 1/20 0.57
SLC6A4 P31645 6/20 0.56
SLC6A2 P23975 5/20 0.56
OPRM1 P35372 1/20 0.50
OPRD1 P41143 1/20 0.50
OPRK1 P41145 1/20 0.50
OPRL1 P41146 1/20 0.50
CYP2C9 P11712 2/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3715253 0.89 CYP1A2 (1.00) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL9366741 0.87 CYP1A2 (0.96) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL9366928 0.84 CYP2D6 (0.79) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL29154466 0.84 CYP1A2 (0.79) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL9366750 0.84 CYP1A2 (0.72) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL9366073 0.84 CYP3A4 (0.72) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL11819427 0.78 CCR3 (0.61) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL11819585 0.78 CCR3 (0.61) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL11819572 0.78 CCR3 (0.61) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL29766950 0.78 CYP1A2 (0.79) CYP1A2CYP2C19CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP claimed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP claimed
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP disclosed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP disclosed